Individual Education on Rational Drug Use in Primary Healthcare for Patients on Long-Term Medication
The Impact of Individual Education on Rational Drug Use in Primary Care for Patients on Long-Term Medication: an Intervention Study
1 other identifier
interventional
365
1 country
1
Brief Summary
Irrational medication use is a common problem in Turkiye and worldwide. Educational interventions are essential to promote rational drug use. This study was conducted to evaluate the effect of individual education on rational drug use given to individuals aged 45-74 years with at least one continuously used medication who applied to a primary health care institution on their rational drug use level. The hypothesis of the study was that individual training on rational drug use given to individuals using medication continuously is effective in increasing rational drug use.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 12, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 16, 2024
CompletedFirst Submitted
Initial submission to the registry
November 20, 2024
CompletedFirst Posted
Study publicly available on registry
November 22, 2024
CompletedNovember 22, 2024
November 1, 2024
11 months
November 20, 2024
November 20, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The effect of individual education on rational drug use status
Rational drug use status of the participants was measured with the Rational Drug Use Scale (RDUS). The RDUS consists of 21 questions and a single dimension. In this 5-point Likert-type scale, the answers for each item are never (1 point), rarely (2 points), sometimes (3 points), often (4 points) and always (5 points). Only the 17th item in the scale is reverse scored. After the reverse scoring process, the 'total scale score' is calculated by summing the scores of all items of the scale. As the total score obtained from RDUS increases, rational drug use also increases. This scale was applied to both arms in both first visit and final visit, and the effect of the educational intervention was evaluated through this scale.
3 months after the first visit of each individual with both the research and control arm
Study Arms (2)
Research Arm
ACTIVE COMPARATORIndividuals in this arm were given individual education on rational drug use by the researcher at the first visit. 'Individual Training Presentation on Rational Drug Use' consisting of visual and written content was used for patient education intervention. After the education, 'Rational Drug Use Patient Brochure' was given to all participants in this arm.
Control Arm
NO INTERVENTIONNo educational intervention was made in the control arm and no brochure was given at the first visit. In line with the principle of equality, participants in this arm were given a patient brochure at the end of the study.
Interventions
In this study, 3 intervention tools were developed by the researchers. The first of these, 'Rational Drug Use Trainer Guide', was used for trainer training and standardisation of the education given to patients. The sample rational drug use presentations prepared by the Ministry of Health, Turkiye Medicines and Medical Devices Agency, Department of Rational Drug Use were combined in terms of content, enriched with information obtained from the literature and developed for the use of family physicians working in primary health care institutions in their clinical practices. 'Rational Drug Use Individual Education Presentation' was prepared by the researchers in line with the 'Rational Drug Use Trainer Guide'. It has been prepared in a format suitable for individual education presentation with the most concise and understandable content suitable for use during primary healthcare service delivery. 'Rational Drug Use Patient Brochure' was prepared by the researchers in a similar content.
Eligibility Criteria
You may qualify if:
- Taking at least one medication continuously (Individuals with taking at least one medication that 'has been used every day for a minimum of 3 months and should be used for at least 1 year' were defined as 'continuous medication users'. Patients' declarations of continuous medication use were verified through the Family Medicine Information System).
- To be between 45-74 years old
- Not being dependent on another individual in terms of medication use
- Being co-operative and orientated (The Mini Mental Test is routinely administered to individuals over the age of 65 who are registered in the Family Medicine Training Unit and the results of this test can be seen in the Family Medicine Information System. In our study, those with normal scores (between 24-30 points) were considered to be co-operative and orientated).
- To be at least primary school graduate
- To agree to participate in the study
You may not qualify if:
- Not to have a medication that is used continuously
- Under 45 years of age or 75 years of age or older
- Being a cancer patient in active treatment
- Being pregnant or breastfeeding
- Having a severe psychiatric disorder
- Uncooperative or disorientated
- Not having completed primary school education
- Getting help from another person for the use of medicines
- In the recruitment of volunteers for the control arm to the 36 groups formed according to the distribution of gender, age groups and education levels of the research arm, the absence of a participant suitable for the characteristics of the group (In order to stabilise the effect of possible confounding variables between the two arms, each participant in the research arm was matched one-to-one with the participants in the control arm in terms of three sociodemographic variables. In the recruitment of volunteers to the control arm, if there was no participant matched to the age group, gender and education level of the participant in the research arm, the participants who were last included in the study in the research arm and could not be matched were excluded from the study).
- Development of a medical condition that prevented participation in the final visit within the three-month follow-up period
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Gülşah Onurlead
Study Sites (1)
Hacettepe University Faculty of Medicine, Department of Family Medicine, Family Medicine Training Unit
Ankara, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gülşah Onur, Research Assistant Dr.
Hacettepe University Faculty of Medicine, Department of Family Medicine
- STUDY DIRECTOR
Duygu Ayhan Başer, Assoc. Prof.
Hacettepe University Faculty of Medicine, Department of Family Medicine
- PRINCIPAL INVESTIGATOR
Bahar (Güçiz) Doğan, Prof.
Hacettepe University Institute of Public Health
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Research Assistant Dr.
Study Record Dates
First Submitted
November 20, 2024
First Posted
November 22, 2024
Study Start
March 1, 2023
Primary Completion
January 12, 2024
Study Completion
April 16, 2024
Last Updated
November 22, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share